Show/hide main menu


News Highlights

Targeting a cause of schizophrenia in the brain

Posted on 27/03/2015

A research collaboration involving scientists from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London has received over £3.2m in funding from the Biomedical Catalyst (BMC) for the first in-human trial of a drug that targets a cause of schizophrenia in the brain.

The project is a collaboration between Autifony Therapeutics, a small business based in London, and researchers from King's College London, The University of Manchester and Newcastle University. The Biomedical Catalyst (BMC) - a partnership between the Medical Research Council (MRC) and Innovate UK - has pledged £32m to 38 projects in universities and companies across the UK. The King’s team, led by Dr Oliver Howes from the Department of Psychosis, will lead the first evaluation of the new treatment in patients using innovative imaging and clinical symptoms. The universities of Manchester and Newcastle will look at models of psychosis in order to examine a mechanism in the brain thought to cause schizophrenia. 

Around one in 100 people will experience schizophrenia in their lifetimes. While it is treated with a combination of medication and therapy tailored to each individual, some with the condition experience a range of other conditions that can have a major impact on their lives. 

Funding from the BMC will support the first trial of a drug that targets one of the defects in the brain linked to schizophrenia. The trial of the drug – which works by acting on the brain circuits that are faulty in schizophrenia – will give vital information on how it acts in the body, what the best dose is and a test to determine how effective it is. This next stage in the development of the drug is supported with over £3.2 million in funding, with £1.15 million from the MRC and £1.25 from Innovate UK. 

Dr Oliver Howes said: ‘Schizophrenia has been called the abandoned illness and it is clear we need new approaches to treating it so it is great to have this support from the MRC and Innovate UK to take a new approach. It will enable us to study an innovative approach to treatment as part of a partnership which will combine the strengths of academia and industry.’

Greg Clark, Minister for Universities, Science and Cities, said: ‘Getting an idea to market is one of the hardest challenges any entrepreneur or small businesses will face when trying to turn their innovative ideas into a reality. The Biomedical Catalyst is giving a real lifeline to research and projects that will help improve or save countless lives.’

Notes to editors

For further media information please contact Jack Stonebridge, Press Officer, Institute of  Psychiatry, Psychology & Neuroscience, King’s College London on or 020 7848 5377. 

Rss Feed Atom Feed

News Highlights:

News Highlights...RSS FeedAtom Feed

Domestic violence leaves physical and psychological scars

Domestic violence leaves physical and psychological scars

In addition to their physical injuries, women who are victims of domestic violence are also at a greater risk of depression and psychotic symptoms, according to a study published in Depression and Anxiety by researchers at the Institute of Psychiatry, Psychology & Neuroscience at King's College London, the Institut universitaire en santé mentale de Montréal (IUSMM) and Université de Montréal.
Dr Andrea Danese receives SRCD award

Dr Andrea Danese receives SRCD award

Dr Andrea Danese of the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) has been awarded the Early Career Research Contribution Award by the Society for Research in Child Development (SRCD).
King's scientists win two Wellcome Image Awards

King's scientists win two Wellcome Image Awards

Captured by scientists at King's, images of a brain astrocyte cell and bundles of nerve fibres inside a human brain have been selected as two of the Wellcome Image Awards 2015 winning images.

Share this story:


Follow Us


Live Twitter feed...

Join the conversation
Sitemap Site help Terms and conditions Privacy policy Accessibility Modern slavery statement Contact us

© 2017 King's College London | Strand | London WC2R 2LS | England | United Kingdom | Tel +44 (0)20 7836 5454